|
Volumn 38, Issue 4, 2001, Pages 376-385
|
Drug interference in clinical chemistry: Recommendation of drugs and their concentrations to be used in drug interference studies
a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ACID PHOSPHATASE;
ASCORBIC ACID;
BILIRUBIN;
CARBAMAZEPINE;
CEFOXITIN;
CREATINE KINASE MB;
CREATININE;
DOBESILATE CALCIUM;
DOXYCYCLINE;
DRUG METABOLITE;
FRUCTOSAMINE;
GENTAMICIN;
IBUPROFEN;
INTRALIPID;
LEVODOPA;
METHYLDOPA;
METRONIDAZOLE;
PARACETAMOL;
PHENYLBUTAZONE;
RHEUMATOID FACTOR;
RIFAMPICIN;
TETRACYCLINE;
THEOPHYLLINE;
TOBRAMYCIN;
URIC ACID;
VALPROIC ACID;
ARTICLE;
CLINICAL CHEMISTRY;
DIAGNOSTIC TEST;
DRUG BLOOD LEVEL;
DRUG COMPETITION;
DRUG URINE LEVEL;
LABORATORY TEST;
PRIORITY JOURNAL;
BLOOD CHEMICAL ANALYSIS;
CHEMISTRY, CLINICAL;
ENZYME TESTS;
EUROPE;
GUIDELINES;
HUMANS;
LABORATORIES;
PHARMACEUTICAL PREPARATIONS;
QUALITY CONTROL;
REPRODUCIBILITY OF RESULTS;
SUBSTANCE-RELATED DISORDERS;
|
EID: 0034937475
PISSN: 00045632
EISSN: None
Source Type: Journal
DOI: 10.1258/0004563011900696 Document Type: Article |
Times cited : (45)
|
References (33)
|